NCT02452008: Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 60 taking part
- Started
- 3 May 2016
- Primary completion
- 8 Dec 2025
- Arms
- Arm 1: Enzalutamide with LY2157299
- Results
- Posted on the registry
- 22 May 2015: Trial registered
- 3 May 2016: Trial started
- 6 Nov 2026: Trial results posted